Most patients with moderately to severely active Crohn’s disease who achieved endoscopic response and remission after 52 ...

Eli Lilly (LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of patients with moderately to ...

Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress: Indianapolis Monday, February 10, 20 ...

The findings were based on the VIVID-2 open-label extension study, which is evaluating the e?cacy and safety of Omvoh for up to three years in adults with moderately to severely active Crohn's ...

More brightness, color, contrast and backlight control all claimed for the second Sky Glass generation — at no extra cost.

The frogs belong to a group called torrent frogs — and they were just discovered as a species new to science. Researchers ...

Vivid Seats Inc. (NASDAQ:SEAT), a provider of online ticket marketplace services with a market capitalization of $925.51 million, has successfully renegotiated the terms of its $393 million Term Loans ...

Sky Glass launched as a way for folks to get hold of a decent TV that could do everything they need without a load of extra ...

Tattoo artists from around the world converged on Paris for a special convention showcasing their creativity and their ...

NOW OPEN: 200 Charter Memberships to Benzinga Trade Alerts On Friday, Eli Lilly And Cao LLY announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).